AzTrials
AzTrials

Neurodevelopmental DisordersmhGAPNCT06702410

WHO Mental Health Gap Action Program (mhGAP) for Improving Child Mental and Behavioral Disorder Service Quality in China

A study testing mental health gap action program intervention guide (mhGAP-IG) in people with Neurodevelopmental Disorders, run by Sun Yat-sen University at 9 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if the adapted mhGAP intervention guide (mhGAP-IG) can improve quality of child mental and behavioral disorders (CMBDs) services in China. It will also learn about the implementation of the mhGAP-IG delivered by kindergarten teachers. Read more about this study

Who is it for?
Ages 2 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Neurodevelopmental Disorders
What is being tested?
mental health gap action program intervention guide (mhGAP-IG)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
375 participants
Where
9 sitesChina
Study dates
20 Nov 2024to 20 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Aged 2-6 years;
  • Screened positive by the mhGAP-IG screening tool;
  • Will stay in Zhongshan City for the next one year.
  • Have one or more years of work experience in the selected kindergartens
  • Be available to participate in the mhGAP training.

Who cannot join

  • Co-morbid physical or mental conditions requiring inpatient hospitalization;
  • Currently or in the past six months received CMBDs services provided by specialized mental health workers;
  • Deafness or blindness in the child or caregivers;
  • Not available or unwilling to participate in the trial.
  • Eligibility criteria for kindergarten teachers
  • Have received the mhGAP training before;
  • Have arrangements requiring long-term leave from work in the next one year;
  • Unwilling to participate in the trial.

Trial locations and contacts

9 sites in 1 country. Contact the study team or a site near you to ask about taking part.

9 sites in 1 country

China9 sites, 4 recruiting
  • Zhongshan Zhengfa Kindergarten

    Zhongshan, Guangdong, 528403

    Xin-yan Bu, 86 15918808828, buxy3@mail2.sysu.edu.cn

    Recruiting
  • Zhongshan Xiaolan Huasheng Kindergarten

    Zhongshan, Guangdong, 528415

    Xue-zhi Liang, 86 13265386106

    Recruiting
  • Zhongshan Dongfeng Deshan Kindergarten

    Zhongshan, Guangdong, 528425

    Ming-lu Yuan, 86 17770917041

    Recruiting
  • Zhongshan Huangpu Boya Oriental Pearl Kindergarten

    Zhongshan, Guangdong, 528429

    Q Zou, zouq25@mail2.sysu.edu.cn

    Recruiting
  • First Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone

    Zhongshan, Guangdong, 528437

    Active, not recruiting
  • Third Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone

    Zhongshan, Guangdong, 528437

    Active, not recruiting
  • Xiao Yin Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone

    Zhongshan, Guangdong, 528437

    Active, not recruiting
  • Zhangjiabian Kindergarten in Zhongshan Torch High-Tech Industrial Development Zone

    Zhongshan, Guangdong, 528437

    Active, not recruiting
  • Shaxi Xin Shimen Kindergarten in Zhongshan City.

    Zhongshan, Guangdong, 528471

    Active, not recruiting

Other trials in China

About this study

Official title: WHO Mental Health Gap Action Program (mhGAP) Delivered by Primary Care Workers for Improving Quality of Child Mental and Behavioral Disorders Services: A Hybrid Effectiveness-implementation Cluster Randomized Controlled Trial

The goal of this clinical trial is to learn if the adapted mhGAP intervention guide (mhGAP-IG) can improve quality of child mental and behavioral disorders (CMBDs) services in China. It will also learn about the implementation of the mhGAP-IG delivered by kindergarten teachers. The main questions it aims to answer are:

  • Does the adapted mhGAP-IG reduce the symptom severity among children with CMBDs between two and sis years old?
  • Does the adapted mhGAP-IG reduce psychological distress among caregivers of children with CMBDs?
  • Does the adapted mhGAP-IG improve mental and behavioral health serivces capacity among kindergarten teachers in China?
  • How is the feasibility, acceptablity, and what are barriers and facilitators of implementation?
Read more

Researchers will compare the adapted mhGAP-IG to child healthcare as usual to see if the adapted mhGAP-IG can improve quality of child mental and behavioral disorders services in China.

Participants (kindergarten teachers) will:

  • Complete questionnaires and scales at baseline and at 3-, 6-, 9- and 12- months of intervention;
  • Receive mhGAP-based trainings;
  • Deliver long-term child mental and behavioral disorders services (including screenings, referals, follow-up, and physcosocial interventions) to children with CMBDs.

Participants (children/caregivers) will:

  • Complete questionnaires and scales at baseline and at 3-, 6- and 12- months of intervention.
  • Accept long-term CMBDs management (including screenings, referals, follow-up management, and physcosocial interventions) from mhGAP-trained kindergarten teachers.
Read the detailed description

Background: Globally, child mental and behavioral disorders (CMBDs) have a high disease burden. The quality of CMBDs services in China, and in many low- and middle-income countries (LMICs), is limited due to the shortage of mental health providers trained to deliver evidence-based clinical care for this population. The WHO Mental Health Gap Action Program Intervention Guide (mhGAP-IG)is an evidence-based training for non-specialist mental health providers in LMICs.

Overall goal: Using a hybrid Type I trial design, To evaluate the effectiveness and implementation of the adapted mhGAP-IG at kindergartens in Guangdong province, China.

Methods: The effectiveness and implementation of the adapted mhGAP-IG will be tested in a stepped-wedge cluster randomized controlled trial. The trail will recruit 20 kindergartens and 375 children in Zhongshan City. Kindergartens will be randomly and subsequently enrolled at regular intervals (steps). At each step, kindergarten teachers will receive the mhGAP-IG training and then cross over from the control condition (providing child mental and behavioral disorders services as usual) to the intervention condition (providing child mental and behavioral disorders services under the adapted mhGAP-IG).

Outcome measures:Symptom severity of CMBDs measured by the Strengths and Difficulties Questionnaire is set as the primary outcome. Implementation measurements will cover the five domains of the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.

Implications: This project will provide additional evidence of the effectiveness of the mhGAP-IG in improving quality of CMBDs services. The lessons learned from this project can aid in scaling the training to other regions of China and LMICs.

Being tested
mental health gap action program intervention guide (mhGAP-IG)
Keywords
neurodevelopmental disorders, task shifting, evidence-based practice, implementation science, stepped wedge trial
Medical subject headings
Neurodevelopmental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mental health gap action program intervention guide (mhGAP-IG)Behavioural

    The mhGAP-IG is an evidence-based intervention developed by WHO. It was designed for non-specialists to scale up high quality mental health services. Although more than 90 countries worldwide have implemented mhGAP-IG, this study is the first to evaluated if it works for scaling up CMBDs services in China. Investigators have cultrually adapted the mhGAP-IG according Chinese context.

Study groups in NCT06702410
Study groupRoleWhat they receive
the adapted mhGAP-IGExperimentalmhGAP-IG-based CMBDs mental health services (including screening, management and follow-up) delivered by trained kindergarten teachers
Receives: Behavioral: mental health gap action program intervention guide (mhGAP-IG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptom severity of CMBDs assessed by Strengths and Difficulties Questionnaire (SDQ)

    A total score ranges from 0 (lowest distress) to 60 (highest distress) and higher scores of SDQ indicate the worse symptom.

    Measured: baseline and 3-, 6- and 12- months of intervention

  2. Developmental domain scores measured by Ages and Stages Questionnaire (ASQ)

    Developmental domain scores derived from ASQ. The ASQ consists of a series of questionnaires specifically designed for children at different months of age. The total score range varies depending on the questionnaire for each age group, but higher scores consistently indicate better development within a particular domain.

    Measured: baseline and 3-, 6- and 12- months of intervention

Secondary outcomes (4)
  1. Caregivers' psychological distress assessed by the Parenting Stress Index-Short Form (PSI-SF)

    A total score ranges from 7 (lowest distress) to 28 (highest distress).

    Measured: baseline and 3-, 6- and 12- months of intervention

  2. Mental health action competence among kindergarten teachers measured by the Chinese version of Mental Health Action Competence (MHAC) Scale.

    A total score ranges from 4 (lowest self-reported competence) to 64 (highest lowest self-reported competence).

    Measured: baseline and 3-, 6-, 9-, and 12- months of intervention

  3. Kownledge level on providing CMBDs services among kindergarten teachers measured by the knowledge questionnaire form the mhGAP-IG

    The questionnaire consists of a series of multiple-choice questions regarding the assessment, management, and follow-up of CMBD. Each correct answer is awarded one point, while incorrect answers receive no points. A higher total score indicates a greater level of knowledge.

    Measured: baseline and 3-, 6-, 9-, and 12- months of intervention

  4. Efficacy score among kindergarten teachers measured by the Chinese short form Teacher Efficacy Scale (TSE).

    The TSE consists of measures for efficacy for instructional strategies, for classroom management, and for student engagement. Both total score or subscale score can derived from TSE, and higher score indicates a greater level of efficacy.

    Measured: baseline and 3-, 6-, 9- and 12- months of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2024
  2. Study start20 Nov 2024
  3. Primary completion20 Feb 2026 (estimated)
  4. Study completion20 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Sequential
Model description
This study use a stepped wedge design. Participants in the same kindergarten are defined as a cluster. The study includes four sequence, each sequence includes five clusters. Each Sequeces will transform into mhGAP-IG intervention as predominated order. Thus the study includes 20 clusters totally.
Masking
None (open label)
Enrolment
375 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06702410
Sponsor's protocol ID
2020-089
Other IDs
20-389, 2022B1515020094
Acronym
mhGAP
Status last verified
May 2025
First submitted
20 Nov 2024
Last updated
16 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing mental health gap action program intervention guide (mhGAP-IG) in people with Neurodevelopmental Disorders, run by Sun Yat-sen University at 9 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wen Chen, Professor (+86 13580520052, chenw43@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptom severity of CMBDs assessed by Strengths and Difficulties Questionnaire (SDQ) (time frame: baseline and 3-, 6- and 12- months of intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
mhGAP Clinical Trial NCT06702410 | AzTrials